Baird Maintains Outperform on Cardinal Health, Raises Price Target to $203
Cardinal Health, Inc. +0.31% Post
Cardinal Health, Inc. CAH | 215.80 215.80 | +0.31% 0.00% Post |
Baird analyst Eric Coldwell maintains Cardinal Health (NYSE:
CAH) with a Outperform and raises the price target from $197 to $203.
